Ventas (VTR) revenue breakdown
By segment, SHOP is the largest at 74% of fiscal 2025 revenue, growing 11% a year over 8 years.
By region, United States is the largest at 89% of fiscal 2025 revenue; Canada grew fastest, 15% a year over 8 years.
Revenue by segment
Fiscal years, as Ventas reports them in its 10-K filings; fiscal 2025 total $5.8B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| SHOP | $1.8B | $2.1B | $2.2B | $2.2B | $2.3B | $2.7B | $3.0B | $3.4B | $4.3B | 74% |
| Outpatient medical and research portfolio (OM&R) | $761M | $784M | $837M | $808M | $803M | $804M | $870M | $878M | $898M | 16% |
| NNN | $845M | $740M | $781M | $695M | $654M | $598M | $619M | $622M | $602M | 10% |
Revenue by region
Fiscal years, as Ventas reports them in its 10-K filings; fiscal 2025 total $5.8B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $3.4B | $3.5B | $3.6B | $3.4B | $3.4B | $3.7B | $4.0B | $4.4B | $5.2B | 89% |
| Canada | $186M | $192M | $267M | $389M | $435M | $449M | $465M | $527M | $553M | 9% |
| United Kingdom | $26M | $29M | $27M | $25M | $30M | $28M | $29M | $31M | $71M | 1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for VTR.
Open VTR in InvestinglyQuestions
Where does Ventas make its money?
In fiscal 2025, by segment: SHOP $4.3B, Outpatient medical and research portfolio (OM&R) $898M, NNN $602M.
From Ventas's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.